特殊酵素市場- 世界の産業規模、シェア、動向、機会、予測、タイプ別、供給源別、用途別、地域別、競合別、2020-2030Fセグメント化

特殊酵素の世界市場規模は2024年に62億2,000万米ドル、予測期間中のCAGRは6.31%で2030年には89億1,000万米ドルに達すると予測されています。

世界の特殊酵素市場は、製薬、診断、食品加工、バイオテクノロジー分野での需要の高まりにより、力強い成長を遂げています。これらの酵素には、プロテアーゼ、カーボハイドラーゼ、リパーゼ、ポリメラーゼが含まれ、特定の反応や用途向けに設計され、高い効率性と選択性を提供します。工業用酵素とは異なり、特殊酵素は少量しか使用されませんが、特に医療診断、治療、研究において高い付加価値をもたらします。製薬業界では、特殊酵素は薬剤製剤、生体触媒、治療薬として、特に酵素欠乏症や代謝性疾患の治療にますます使用されるようになっています。慢性疾患の増加、人口の高齢化、個別化医療への関心が需要をさらに促進しています。分子診断学では、ポリメラーゼやヌクレアーゼなどの酵素がDNAの増幅と分析において重要な役割を果たし、病気の検出の精度と速度を高めています。

市場促進要因

高度なヘルスケアソリューションに対する需要の高まり

主な市場課題

高い製造コスト

主要市場動向

持続可能性と生体触媒作用

目次

第1章 概要

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 世界の特殊酵素市場展望

• 市場規模・予測
  • 金額・数量別
• 市場シェア・予測
  • タイプ別（プロテアーゼ、ポリメラーゼ、ヌクレアーゼ、炭水化物分解酵素、リパーゼなど）
  • 発生源別（微生物、植物、動物）
  • 用途別（バイオテクノロジー、医薬品、診断、研究開発）
  • 地域別（北米、欧州、アジア太平洋、南米、中東・アフリカ）
  • 企業別（2024）
• 市場マップ
  • タイプ別
  • ソース別
  • 用途別
  • 地域別
• 価格分析

第5章 欧州の特殊酵素市場展望

• 市場規模・予測
  • 金額・数量別
• 市場シェア・予測
  • タイプ別（プロテアーゼ、ポリメラーゼ、ヌクレアーゼ、炭水化物分解酵素、リパーゼなど）
  • 発生源別（微生物、植物、動物）
  • 用途別（バイオテクノロジー、医薬品、診断、研究開発）
  • 地域別
• 価格分析
• 欧州：国別分析
  • フランス
  • ドイツ
  • 英国
  • イタリア
  • スペイン

第6章 アジア太平洋地域の特殊酵素市場展望

• 市場規模・予測
• 市場シェア・予測
• 価格分析
• アジア太平洋地域：国別分析
  • 中国
  • インド
  • 日本
  • 韓国
  • オーストラリア

第7章 北米の特殊酵素市場展望

• 市場規模・予測
• 市場シェア・予測
• 価格分析
• 北米：国別分析
  • 米国
  • カナダ
  • メキシコ

第8章 中東・アフリカの特殊酵素市場展望

• 市場規模・予測
• 市場シェア・予測
• 価格分析
• 中東・アフリカ：国別分析
  • サウジアラビア
  • 南アフリカ
  • アラブ首長国連邦

第9章 南米の特殊酵素市場展望

• 市場規模・予測
• 市場シェア・予測
• 価格分析
• 南米：国別分析
  • ブラジル
  • コロンビア
  • アルゼンチン

第10章 市場力学

• 促進要因
  • 消化器疾患の罹患率の増加
  • 医薬品製造における高い使用率
  • 多国籍酵素メーカーによるバイオテクノロジーと遺伝学への継続的な投資
• 課題
  • 高コストとメンテナンスの問題
  • 規制上の課題

第11章 市場動向と発展

• 最近の動向
• 合併と買収
• 製品上市

第12章 世界の特殊酵素市場：SWOT分析

第13章 ポーターのファイブフォース分析

• 業界内の競合
• 新規参入の可能性
• サプライヤーの力
• 顧客の力
• 代替品の脅威

第14章 競合情勢

• F. Hoffmann-La Roche AG
• Codexis Inc.
• BASF SE
• Koninklijke DSM N.V.
• DuPont Nutrition Biosciences
• Advanced Enzyme Technologies Limited
• Novozymes A/S
• Amano enzyme Inc.
• BBI Solutions OEM Limited
• Sekisui Diagnostics

第15章 戦略的提言

第16章 調査会社について・免責事項

Global Specialty Enzymes Market was valued at USD 6.22 billion in 2024 and is expected to reach USD 8.91 billion by 2030 with a CAGR of 6.31% during the forecast period. The global specialty enzymes market is experiencing strong growth, driven by rising demand across pharmaceuticals, diagnostics, food processing, and biotechnology sectors. These enzymes, which include proteases, carbohydrases, lipases, and polymerases, are designed for specific reactions and applications, offering high efficiency and selectivity. Unlike industrial enzymes, specialty enzymes are used in smaller volumes but add high value, particularly in medical diagnostics, therapeutics, and research. In the pharmaceutical industry, specialty enzymes are increasingly used in drug formulation, biocatalysis, and as therapeutic agents, especially for treating enzyme deficiency disorders and metabolic conditions. The rise in chronic diseases, aging populations, and interest in personalized medicine are further fueling demand. In molecular diagnostics, enzymes such as polymerases and nucleases play a crucial role in DNA amplification and analysis, enhancing the accuracy and speed of disease detection.

Key Market Drivers

Growing demand for advanced healthcare solutions

The growing demand for advanced healthcare solutions is significantly impacting the specialty enzymes market. As healthcare systems around the world shift towards precision medicine, targeted therapies, and early diagnostics, specialty enzymes have emerged as essential components in these innovations. These enzymes are tailored for specific biological reactions, making them ideal for complex medical applications such as drug formulation, gene therapy, and diagnostic testing. In drug development, specialty enzymes are used to synthesize active pharmaceutical ingredients with high specificity and fewer side effects. They also support biocatalysis processes that enhance the efficiency and environmental sustainability of pharmaceutical manufacturing. Enzyme replacement therapies, which treat rare genetic and metabolic disorders, are gaining traction as awareness and diagnosis improve. This has created a surge in demand for enzymes that can be used directly as therapeutic agents. In diagnostics, specialty enzymes enable accurate and rapid detection of diseases through applications such as polymerase chain reactions (PCR), ELISA tests, and next-generation sequencing. These tools have become increasingly important in identifying conditions ranging from infectious diseases to cancer and genetic disorders.

With aging populations and a rise in lifestyle-related illnesses, there is increased pressure on healthcare systems to adopt technologies that are both effective and scalable. Specialty enzymes support this need by improving treatment outcomes and enabling high-throughput diagnostic platforms. Biotechnology and pharmaceutical companies are investing in enzyme engineering to develop more stable and efficient products. As healthcare moves toward more personalized, data-driven models, the role of specialty enzymes in diagnostics and therapeutics will continue to expand significantly.

Key Market Challenges

High production cost

High production cost is a significant barrier in the specialty enzymes market. These enzymes are typically produced through advanced biotechnological methods such as microbial fermentation, recombinant DNA technology, and protein engineering. Each stage of development-from strain selection and genetic modification to purification and formulation-requires specialized equipment, skilled labor, and stringent quality control, all of which contribute to elevated manufacturing costs. The complexity of maintaining enzyme activity and stability throughout the production process further adds to expenses. Specialty enzymes often need to retain functionality under specific pH, temperature, or moisture conditions, which calls for customized formulations and storage solutions. These requirements make large-scale production more expensive compared to standard industrial enzymes. For pharmaceutical and diagnostic applications, the cost increases due to the need for clinical validation, regulatory compliance, and purity standards. High-purity enzymes must be free from contaminants and consistent in performance, leading to costly purification and testing procedures. This financial burden can limit the adoption of specialty enzymes, especially in emerging markets or in price-sensitive sectors such as food processing. The high cost of production also impacts pricing strategies, reducing profit margins and making it harder for smaller companies to compete. Reducing production costs through innovation and process optimization is key to expanding market access.

Key Market Trends

Sustainability & Biocatalysis

Sustainability and biocatalysis are becoming central drivers in the specialty enzymes market, as industries seek cleaner, greener alternatives to traditional chemical processes. Enzymes act as biocatalysts, enabling environmentally friendly reactions with high specificity and lower energy requirements. This aligns with global efforts to reduce carbon footprints and minimize hazardous waste across sectors like pharmaceuticals, textiles, food processing, and biofuels. In chemical manufacturing, enzymes replace harsh solvents and high-temperature reactions, supporting eco-friendly production while improving process efficiency. This shift is particularly important in regulated industries under increasing pressure to meet sustainability benchmarks and environmental standards. Biocatalysis also offers benefits such as reduced water consumption and fewer byproducts, which help companies optimize resource usage and reduce costs. In biofuel production, enzymes play a vital role in breaking down biomass into fermentable sugars, supporting the transition to renewable energy sources. Governments and private investors are backing such enzyme-based innovations to achieve climate targets and foster circular economy practices. Consumer demand for sustainable products is also influencing manufacturers to integrate biocatalysts into their workflows.The push for green chemistry is expected to accelerate investment in enzyme discovery, engineering, and industrial-scale application. Biocatalysis is not just a technological advancement-it is a strategic necessity for companies aiming to lead in a sustainable future.

Key Market Players

• F. Hoffmann-La Roche AG
• Codexis Inc.
• BASF SE
• Koninklijke DSM N.V.
• DuPont Nutrition Biosciences
• Advanced Enzyme Technologies Limited
• Novozymes A/S
• Amano enzyme Inc.
• BBI Solutions OEM Limited
• Sekisui Diagnostics

Report Scope:

In this report, the Global Specialty Enzymes Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Specialty Enzymes Market, By Type:

• Proteases
• Polymerases & Nucleases
• Carbohydrases
• Lipases
• Others

Specialty Enzymes Market, By Source:

• Microorganisms
• Plants
• Animals

Specialty Enzymes Market, By Application:

• Biotechnology
• Pharmaceuticals
• Diagnostics
• Research & Development

Specialty Enzymes Market, By Region:

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Specialty Enzymes Market.

Available Customizations:

Global Specialty Enzymes Market report with the given Market data, TechSci Research, offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional Market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Global Specialty Enzymes Market Outlook

• 4.1. Market Size & Forecast
  • 4.1.1. By Value & Volume
• 4.2. Market Share & Forecast
  • 4.2.1. By Type (Proteases, Polymerases & Nucleases, Carbohydrase's, Lipases, And Others)
  • 4.2.2. By Source (Microorganisms, Plants, Animals)
  • 4.2.3. By Application (Biotechnology, Pharmaceuticals, Diagnostics, And Research & Development)
  • 4.2.4. By Region (North America, Europe, Asia Pacific, South America, Middle East & Africa)
  • 4.2.5. By Company (2024)
• 4.3. Market Map
  • 4.3.1. By Type
  • 4.3.2. By Source
  • 4.3.3. By Application
  • 4.3.4. By Region
• 4.4. Pricing Analysis

5. Europe Specialty Enzymes Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value & Volume
• 5.2. Market Share & Forecast
  • 5.2.1. By Type (Proteases, Polymerases & Nucleases, Carbohydrase's, Lipases, And Others)
  • 5.2.2. By Source (Microorganisms, Plants, Animals)
  • 5.2.3. By Application (Biotechnology, Pharmaceuticals, Diagnostics, And Research & Development)
  • 5.2.4. By Region
• 5.3. Pricing Analysis
• 5.4. Europe: Country Analysis
  • 5.4.1. France Specialty Enzymes Market Outlook
    • 5.4.1.1. Market Size & Forecast
      • 5.4.1.1.1. By Value & Volume
    • 5.4.1.2. Market Share & Forecast
      • 5.4.1.2.1. By Type
      • 5.4.1.2.2. By Source
      • 5.4.1.2.3. By Application
  • 5.4.2. Germany Specialty Enzymes Market Outlook
    • 5.4.2.1. Market Size & Forecast
      • 5.4.2.1.1. By Value & Volume
    • 5.4.2.2. Market Share & Forecast
      • 5.4.2.2.1. By Type
      • 5.4.2.2.2. By Source
      • 5.4.2.2.3. By Application
  • 5.4.3.United Kingdom Specialty Enzymes Market Outlook
    • 5.4.3.1. Market Size & Forecast
      • 5.4.3.1.1. By Value & Volume
    • 5.4.3.2. Market Share & Forecast
      • 5.4.3.2.1. By Type
      • 5.4.3.2.2. By Source
      • 5.4.3.2.3. By Application
  • 5.4.4. Italy Specialty Enzymes Market Outlook
    • 5.4.4.1. Market Size & Forecast
      • 5.4.4.1.1. By Value & Volume
    • 5.4.4.2. Market Share & Forecast
      • 5.4.4.2.1. By Type
      • 5.4.4.2.2. By Source
      • 5.4.4.2.3. By Application
  • 5.4.5. Spain Specialty Enzymes Market Outlook
    • 5.4.5.1. Market Size & Forecast
      • 5.4.5.1.1. By Value & Volume
    • 5.4.5.2. Market Share & Forecast
      • 5.4.5.2.1. By Type
      • 5.4.5.2.2. By Source
      • 5.4.5.2.3. By Application

6. Asia-Pacific Specialty Enzymes Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value & Volume
• 6.2. Market Share & Forecast
  • 6.2.1. By Type (Proteases, Polymerases & Nucleases, Carbohydrase's, Lipases, And Others)
  • 6.2.2. By Source (Microorganisms, Plants, Animals)
  • 6.2.3. By Application (Biotechnology, Pharmaceuticals, Diagnostics, And Research & Development)
  • 6.2.4. By Region
• 6.3. Pricing Analysis
• 6.4. Asia-Pacific: Country Analysis
  • 6.4.1. China Specialty Enzymes Market Outlook
    • 6.4.1.1. Market Size & Forecast
      • 6.4.1.1.1. By Value & Volume
    • 6.4.1.2. Market Share & Forecast
      • 6.4.1.2.1. By Type
      • 6.4.1.2.2. By Source
      • 6.4.1.2.3. By Application
  • 6.4.2. India Specialty Enzymes Market Outlook
    • 6.4.2.1. Market Size & Forecast
      • 6.4.2.1.1. By Value & Volume
    • 6.4.2.2. Market Share & Forecast
      • 6.4.2.2.1. By Type
      • 6.4.2.2.2. By Source
      • 6.4.2.2.3. By Application
  • 6.4.3. Japan Specialty Enzymes Market Outlook
    • 6.4.3.1. Market Size & Forecast
      • 6.4.3.1.1. By Value & Volume
    • 6.4.3.2. Market Share & Forecast
      • 6.4.3.2.1. By Type
      • 6.4.3.2.2. By Source
      • 6.4.3.2.3. By Application
  • 6.4.4. South Korea Specialty Enzymes Market Outlook
    • 6.4.4.1. Market Size & Forecast
      • 6.4.4.1.1. By Value & Volume
    • 6.4.4.2. Market Share & Forecast
      • 6.4.4.2.1. By Type
      • 6.4.4.2.2. By Source
      • 6.4.4.2.3. By Application
  • 6.4.5. Australia Specialty Enzymes Market Outlook
    • 6.4.5.1. Market Size & Forecast
      • 6.4.5.1.1. By Value & Volume
    • 6.4.5.2. Market Share & Forecast
      • 6.4.5.2.1. By Type
      • 6.4.5.2.2. By Source
      • 6.4.5.2.3. By Application
      • 6.4.5.2.4. By Application

7. North America Specialty Enzymes Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value & Volume
• 7.2. Market Share & Forecast
  • 7.2.1. By Type (Proteases, Polymerases & Nucleases, Carbohydrase's, Lipases, And Others)
  • 7.2.2. By Source (Microorganisms, Plants, Animals)
  • 7.2.3. By Application (Biotechnology, Pharmaceuticals, Diagnostics, And Research & Development)
  • 7.2.4. By Region
• 7.3. Pricing Analysis
• 7.4. North America: Country Analysis
  • 7.4.1. United States Specialty Enzymes Market Outlook
    • 7.4.1.1. Market Size & Forecast
      • 7.4.1.1.1. By Value & Volume
    • 7.4.1.2. Market Share & Forecast
      • 7.4.1.2.1. By Type
      • 7.4.1.2.2. By Source
      • 7.4.1.2.3. By Application
  • 7.4.2. Canada Specialty Enzymes Market Outlook
    • 7.4.2.1. Market Size & Forecast
      • 7.4.2.1.1. By Value & Volume
    • 7.4.2.2. Market Share & Forecast
      • 7.4.2.2.1. By Type
      • 7.4.2.2.2. By Source
      • 7.4.2.2.3. By Application
  • 7.4.3. Mexico Specialty Enzymes Market Outlook
    • 7.4.3.1. Market Size & Forecast
      • 7.4.3.1.1. By Value & Volume
    • 7.4.3.2. Market Share & Forecast
      • 7.4.3.2.1. By Type
      • 7.4.3.2.2. By Source
      • 7.4.3.2.3. By Application

8. Middle East and Africa Specialty Enzymes Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value & Volume
• 8.2. Market Share & Forecast
  • 8.2.1. By Type (Proteases, Polymerases & Nucleases, Carbohydrase's, Lipases, And Others)
  • 8.2.2. By Source (Microorganisms, Plants, Animals)
  • 8.2.3. By Application (Biotechnology, Pharmaceuticals, Diagnostics, And Research & Development)
  • 8.2.4. By Region
• 8.3. Pricing Analysis
• 8.4. MEA: Country Analysis
  • 8.4.1. Saudi Arabia Specialty Enzymes Market Outlook
    • 8.4.1.1. Market Size & Forecast
      • 8.4.1.1.1. By Value & Volume
    • 8.4.1.2. Market Share & Forecast
      • 8.4.1.2.1. By Type
      • 8.4.1.2.2. By Source
      • 8.4.1.2.3. By Application
  • 8.4.2. South Africa Specialty Enzymes Market Outlook
    • 8.4.2.1. Market Size & Forecast
      • 8.4.2.1.1. By Value & Volume
    • 8.4.2.2. Market Share & Forecast
      • 8.4.2.2.1. By Type
      • 8.4.2.2.2. By Source
      • 8.4.2.2.3. By Application
  • 8.4.3. UAE Specialty Enzymes Market Outlook
    • 8.4.3.1. Market Size & Forecast
      • 8.4.3.1.1. By Value & Volume
    • 8.4.3.2. Market Share & Forecast
      • 8.4.3.2.1. By Type
      • 8.4.3.2.2. By Source
      • 8.4.3.2.3. By Application

9. South America Specialty Enzymes Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value & Volume
• 9.2. Market Share & Forecast
  • 9.2.1. By Type (Proteases, Polymerases & Nucleases, Carbohydrase's, Lipases, And Others)
  • 9.2.2. By Source (Microorganisms, Plants, Animals)
  • 9.2.3. By Application (Biotechnology, Pharmaceuticals, Diagnostics, And Research & Development)
  • 9.2.4. By Region
• 9.3. Pricing Analysis
• 9.4. South America: Country Analysis
  • 9.4.1. Brazil Specialty Enzymes Market Outlook
    • 9.4.1.1. Market Size & Forecast
      • 9.4.1.1.1. By Value & Volume
    • 9.4.1.2. Market Share & Forecast
      • 9.4.1.2.1. By Type
      • 9.4.1.2.2. By Source
      • 9.4.1.2.3. By Application
  • 9.4.2. Colombia Specialty Enzymes Market Outlook
    • 9.4.2.1. Market Size & Forecast
      • 9.4.2.1.1. By Value & Volume
    • 9.4.2.2. Market Share & Forecast
      • 9.4.2.2.1. By Type
      • 9.4.2.2.2. By Source
      • 9.4.2.2.3. By Application
  • 9.4.3. Argentina Specialty Enzymes Market Outlook
    • 9.4.3.1. Market Size & Forecast
      • 9.4.3.1.1. By Value & Volume
    • 9.4.3.2. Market Share & Forecast
      • 9.4.3.2.1. By Type
      • 9.4.3.2.2. By Source
      • 9.4.3.2.3. By Application

10. Market Dynamics

• 10.1. Drivers
  • 10.1.1. Increasing Prevalence of Digestive Disorders
  • 10.1.2. High Usage in Drugs Manufacturing
  • 10.1.3. Continued Investment in Biotechnology and Genetics by Various Multinational Enzyme Manufacturers
• 10.2. Challenges
  • 10.2.1. High cost and Maintenance Issues
  • 10.2.2. Regulatory challenges

11. Market Trends & Developments

• 11.1. Recent Developments
• 11.2. Mergers & Acquisitions
• 11.3. Product Launches

12. Global Specialty Enzymes Market: SWOT Analysis

13. Porter's Five Forces Analysis

• 13.1. Competition in the Industry
• 13.2. Potential of New Entrants
• 13.3. Power of Suppliers
• 13.4. Power of Customers
• 13.5. Threat of Substitute Products

14. Competitive Landscape

• 14.1. F. Hoffmann-La Roche AG
  • 14.1.1. Business Overview
  • 14.1.2. Company Snapshot
  • 14.1.3. Products & Services
  • 14.1.4. Financials (As Reported)
  • 14.1.5. Recent Developments
  • 14.1.6. SWOT Analysis
• 14.2. Codexis Inc.
• 14.3. BASF SE
• 14.4. Koninklijke DSM N.V.
• 14.5. DuPont Nutrition Biosciences
• 14.6. Advanced Enzyme Technologies Limited
• 14.7. Novozymes A/S
• 14.8. Amano enzyme Inc.
• 14.9. BBI Solutions OEM Limited
• 14.10. Sekisui Diagnostics

15. Strategic Recommendations

16. About Us & Disclaimer